世界の肝臓がん診断市場
Market Size in USD Billion
CAGR :
% 
USD
7,520.00 Million
USD
12,445.57 Million
2022
2030
 予測期間 |
2023 –2030 |
 市場規模（基準年） |
USD 7,520.00 Million |
 Market Size (Forecast Year) |
USD 12,445.57 Million |
 CAGR |
% |
| 主要市場プレーヤー |
世界の肝臓がん診断市場、検査タイプ別（画像検査、生検、ゲノム検査、その他）、がんのステージ（ステージ0、ステージI、ステージII、ステージIII、ステージIV）、がんの種類（原発性肝臓がん、続発性肝臓がん）、製品（プラットフォームベースの製品、機器ベースの製品、キットおよび試薬、その他の消耗品）、技術（蛍光in situハイブリダイゼーション、次世代シーケンシング、蛍光免疫測定法、比較ゲノムハイブリダイゼーション、免疫組織化学、その他）、用途（スクリーニング、診断および予測、予後、研究）、性別（女性と男性）、エンドユーザー（病院、診断センター、がん研究センター、学術機関、外来手術センター、その他）、流通チャネル（直接入札、小売販売、その他） - 2030年までの業界動向と予測。
肝臓がん診断市場の分析と洞察
世界の肝臓がん診断市場は、市場プレーヤーの増加と高度なサービスの利用可能性により、予測年度に成長すると予想されています。これに伴い、メーカーは市場に新しいサービスを立ち上げるための研究開発活動に取り組んでいます。肝臓がんに対するより質の高いヘルスケアの需要の高まりと、予防的健康診断の好みの高まりにより、市場の成長が促進されると予想されます。
しかし、診断手順のコストの高さと、熟練した認定専門家の不足が、市場の成長に課題をもたらすと予想されます。
世界の肝臓がん診断市場は、2023年から2030年の予測期間に市場成長を遂げると予想されています。データブリッジマーケットリサーチは、市場は2023年から2030年の予測期間に6.5%のCAGRで成長し、2022年の75億2,000万米ドルから2030年には124億4,557万米ドルに達すると分析しています。
当社のチームは、お客様が希望する目標を達成するための収益インパクトソリューションの作成をお手伝いします。さまざまな地域の発展途上国における小売ユニットの拡張性と事業拡大、および機械および医薬品の安全な流通のためのサプライヤーとのパートナーシップは、予測期間中の市場の需要を推進する主な原動力です。
|
レポートメトリック |
詳細 |
|
予測期間 |
2023年から2030年 |
|
基準年 |
2022 |
|
歴史的な年 |
2021 (2015～2020年にカスタマイズ可能) |
|
定量単位 |
収益（百万米ドル） |
|
対象セグメント |
検査タイプ別（画像検査、生検、ゲノム検査、その他）、がんのステージ別（ステージ 0、ステージ I、ステージ II、ステージ III、ステージ IV）、がんの種類別（原発性肝がん、続発性肝がん）、製品別（プラットフォームベースの製品、機器ベースの製品、キットおよび試薬、その他の消耗品）、技術別（蛍光 in situ ハイブリダイゼーション、次世代シーケンシング、蛍光免疫測定法、比較ゲノムハイブリダイゼーション、免疫組織化学、その他）、用途別（スクリーニング、診断および予測、予後、研究）、性別別（女性および男性）、エンドユーザー別（病院、診断センター、がん研究センター、学術機関、外来手術センター、その他）、流通チャネル別（直接入札、小売販売、その他） |
|
対象国 |
米国、カナダ、メキシコ、ドイツ、フランス、英国、イタリア、ロシア、スペイン、オランダ、スイス、ノルウェー、ポーランド、スウェーデン、ベルギー、トルコ、デンマーク、フィンランド、その他のヨーロッパ諸国、中国、日本、インド、オーストラリア、韓国、シンガポール、マレーシア、タイ、インドネシア、フィリピン、ベトナム、その他のアジア太平洋諸国、南アフリカ、サウジアラビア、エジプト、イスラエル、その他の中東およびアフリカ諸国、ブラジル、アルゼンチン、その他の南米諸国 |
|
対象となる市場プレーヤー |
Siemens Healthcare GmbH（ドイツ）、Koninklijke Philips NV（オランダ）、Agilent Technologies, Inc.（米国）、Illumina, Inc.（米国）、Epigenomics AG（ドイツ）、Tebubio、Thermo Fisher Scientific Inc.（米国）、QIAGEN（米国）、F. Hoffmann-La Roche Ltd（スイス）、富士レビオ（日本）、Diagnostic Biosystems Inc.（米国）、富士フイルム株式会社（日本）、BD（米国）、Q-LINE BIOTECH PVT LTD.（インド）、MOLGEN（オランダ）、BIOCEPT, INC.（米国）、シスメックス株式会社（日本）、Boditech Med Inc.、Elabscience Biotechnology Inc.（米国）、Hipro Biotechnology Co., Ltd.（中国）、Altogen Biosystems（米国）、Tosoh India Pvt. Ltd.（インド）、ABK Biomedical Inc.（カナダ）、Diazyme Laboratories, Inc.（米国）、AB Sciex Pte Ltd.（Danaherの子会社）（米国）など |
市場の定義
肝臓がんの診断とは、肝臓がんの検出と診断に使用されるさまざまな方法と技術を指します。これには、臨床検査、画像検査、身体検査が含まれます。
肝臓がん診断市場には、診断研究所、医療機器メーカー、製薬会社など、さまざまな企業による幅広い製品とサービスが含まれます。この市場は、肝臓がんの発生率の増加と、正確で信頼性の高い診断検査に対する需要の高まりによって推進されています。
世界の肝臓がん診断市場の動向
ドライバー
- がんの早期発見のための非侵襲的、正確かつ信頼性の高い診断検査に対する満たされていないニーズ
Diagnostics is also becoming an increasingly important tool for converting the most recent developments in basic research into better clinical outcomes for patients. The development of novel, quick, sensitive, less invasive, and more accurate molecular diagnostic tests is being accelerated by some of the most exciting scientific developments of the time, including genomics, proteomics, and other "omics" technologies. This significantly impacts the ability to identify and treat different cancers earlier and more precisely. By customizing medicines based on each patient's distinct molecular profile, diagnostics help doctors make better-educated treatment decisions.
Thus, the unmet need for non-invasive, accurate, and reliable diagnostic tests for earlier cancer detection demands is expected to drive the market's growth.
- Increasing early diagnosis of liver cancer
Machine learning could revolutionize early cancer diagnosis, which trains computers to see patterns in complex data. Tools include assessments of common health data, medical imaging, biopsy samples, and blood tests to help in early diagnosis and risk stratification. In many tumor types, the likelihood of undergoing successful therapy increases with an early cancer diagnosis. One important strategy is to assess patients at risk who do not exhibit symptoms and respond quickly and appropriately to those who do.
Thus, earlier detection improves treatment options, patient outcomes, and survival and is expected to drive the growth of the global liver cancer diagnostics market.
Restraint
- Barriers to liver cancer diagnosis and poor prognosis
Cancer is the leading cause of death in developed and developing countries. Cancer mortality is expected to rise to an estimated 13.1 million deaths annually by 2030. However, certain types of cancer have a high chance of being cured if they are detected at an early stage and adequately treated. The delays in cancer diagnosis may occur throughout the diagnostic pathway: patient, primary care, and secondary care. Patient delays may occur when the patient fails to recognize and act on suspicious cancer symptoms. Poor public awareness of early cancer symptoms is considered the predominant reason for delayed presentation, particularly if symptoms are atypical in nature.
The late diagnosis often results from these factors, which result in poor prognosis. Thus, these are expected to restrain the growth of the global liver cancer diagnostics market.
Opportunity
-
Increasing awareness towards liver cancer
Liver cancer awareness is a chance to increase knowledge about these diseases and to put the spotlight on research into their causes, prevention, diagnosis, treatment, and survival. The objective is to assist persons who have been impacted by the liver and to promote healthy habits. Primary liver cancer is the name for cancer that develops in the liver. Hepatocellular carcinoma is the most prevalent type of primary liver cancer in adults (HCC). The third most common cause of cancer-related fatalities worldwide is this particular form of liver cancer. About 25,000 men and 11,000 women are diagnosed with liver cancer each year in the US, and the illness claims the lives of 19,000 men and 9,000 women.
Thus, government initiatives toward liver cancer diagnostics is expected to create an opportunity for the growth of the market.
Challenge
- Strict regulations for the approval of liver cancer diagnostic products
The strict guidelines for product approval and market commercialization are proving to be a major obstacle for manufacturers of cancer diagnostic products worldwide. Every nation has its own regulations and employs a different regulating body.
The players involved in the production and marketing of medical devices must adjust as a result of the strict regulations. This would affect all stakeholders globally, which is projected to challenge the market throughout the forecast period. Thus, it is expected to act as a challenge for the global liver cancer diagnostics market to hamper its growth.
Recent Development
- In December 2022, FUJIFILM Holdings America Corporation announced the company has a purchase agreement asset with Inspirata, Inc. to acquire a digital pathology business to expand its robust enterprise imaging offering. This results in enabling the integration of pathology images and data into a healthcare organization’s electronic health record system to streamline care delivery for oncology patients
Global Liver Cancer Diagnostics Market Scope
The global liver cancer diagnostics market is categorized into nine notable segments, which are test type, cancer type, cancer stages, product, application, technology, gender, end-user, and distribution channels.
By Test Type
- Imaging Test
- Biopsy
- Genomic Test
- Others
By Cancer Stages
- Stage 0
- Stage I
- Stage II
- Stage III
- Stage IV
By Cancer Type
- Primary Liver Cancer
- Secondary Liver Cancer
By Product
- Platform-Based Products
- Instrument-Based Products
- Kits And Reagents
- Other Consumables
By Technology
- Fluorescent In Situ Hybridization
- Next Generation Sequencing
- Fluoroimmunoassay
- Comparative Genomic Hybridization
- Immunohistochemical
- Others
By Application
- Screening
- Diagnostic And Predictive
- Prognostic
- Research
By Gender
- Female
- Male
By End-User
- Hospitals
- Cancer Research Centers
- Academic Institutes
- Diagnostic Centers
- Ambulatory Surgical Centers
- Others
By Distribution Channel
- Direct Tenders
- Retail Sales
- Others
Global Liver Cancer Diagnostics Market Regional Analysis/Insights
The global liver cancer diagnostics market is segmented into nine notable segments based on test type, cancer stages, cancer type, product, application, technology, gender, end-user, and distribution channel.
The countries covered in this market report are the U.S., Canada, and Mexico. Europe is segmented into Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Norway, Belgium, Turkey, and the rest of Europe. Asia-Pacific is segmented into China, Japan, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, and the rest of Asia-Pacific. The Middle East and Africa are segmented into South Africa, Saudi Arabia, U.A.E, Egypt, Israel, and the rest of the Middle East and Africa. South America is segmented into Brazil, Argentina, and the rest of South America.
North America is dominating the market due to the increasing investment in R&D is expected to boost the market growth. U.S. dominates the North America region due to the strong presence of key players Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Koninklijke Philips N.V., and Agilent Technologies, Inc. China dominates the Asia-Pacific region due to the mass production of liver cancer diagnostics products and increasing demand from emerging markets and expansion.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Global liver cancer diagnostics market Share Analysis
Global liver cancer diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breath, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the Global liver cancer diagnostics market.
世界の肝臓がん診断市場で活動している主要企業には、Siemens Healthcare GmbH（ドイツ）、Koninklijke Philips NV（オランダ）、Agilent Technologies, Inc.（米国）、Illumina, Inc.（米国）、Epigenomics AG（ドイツ）、Tebubio、Thermo Fisher Scientific Inc.（米国）、QIAGEN（米国）、F. Hoffmann-La Roche Ltd（スイス）、富士レビオ（日本）、Diagnostic Biosystems Inc.（米国）、富士フイルム株式会社（日本）、BD（米国）、Q-LINE BIOTECH PVT LTD.（インド）、MOLGEN（オランダ）、BIOCEPT, INC.（米国）、シスメックス株式会社（日本）、Boditech Med Inc.、Elabscience Biotechnology Inc.（米国）、Hipro Biotechnology Co., Ltd.（中国）、Altogen Biosystems（米国）、Tosoh India Pvt.（インド）などがあります。 Ltd.（インド）、ABK Biomedical Inc.（カナダ）、Diazyme Laboratories, Inc.（米国）、AB Sciex Pte Ltd.（Danaherの子会社）（米国）など。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL LIVER CANCER DIAGNOSTICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 TEST TYPE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.2 PORTER ANALYSIS
4.3 EPIDEMIOLOGY
5 GLOBAL LIVER CANCER DIAGNOSTICS MARKET, REGULATIONS
6 INDUSTRY INSIGHTS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 UNMET NEED FOR NON-INVASIVE, ACCURATE, AND RELIABLE DIAGNOSTIC TESTS FOR EARLIER CANCER DETECTION
7.1.2 INCREASING EARLY DIAGNOSIS OF LIVER CANCER
7.1.3 INCREASING CASES OF LIVER CANCER
7.1.4 RISE IN DIAGNOSTIC PRODUCT APPROVALS
7.2 RESTRAINTS
7.2.1 BARRIERS TO LIVER CANCER DIAGNOSIS AND POOR PROGNOSIS
7.2.2 HIGH FALSE-POSITIVES AND POOR SENSITIVITY OF LIVER CANCER DIAGNOSIS
7.3 OPPORTUNITIES
7.3.1 INCREASING AWARENESS TOWARDS LIVER CANCER
7.3.2 GOVERNMENT INITIATIVES TOWARD LIVER CANCER DIAGNOSTICS
7.3.3 GROWING DEMAND FOR BETTER QUALITY HEALTHCARE
7.4 CHALLENGES
7.4.1 STRICT REGULATIONS FOR THE APPROVAL OF LIVER CANCER DIAGNOSTIC PRODUCTS
7.4.2 LACK OF SKILLED AND CERTIFIED EXPERTISE
8 GLOBAL LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE
8.1 OVERVIEW
8.2 IMAGING TEST
8.2.1 MAGNETIC RESONANCE IMAGING (MRI)
8.2.1.1 MR ANGIOGRAPHY (MRA)
8.2.1.2 MR CHOLANGIOPANCREATOGRAPHY
8.2.2 COMPUTED TOMOGRAPHY
8.2.3 POSITRON EMISSION TOMOGRAPHY
8.2.4 ULTRASOUND
8.2.5 OTHERS
8.3 GENOMIC TEST
8.4 BIOPSY
8.4.1 FINE NEEDLE ASPIRATION BIOPSY
8.4.2 CORE NEEDLE BIOPSY
8.4.3 LAPAROSCOPY
8.5 OTHERS
9 GLOBAL LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGE
9.1 OVERVIEW
9.2 STAGE III
9.3 STAGE II
9.4 STAGE IV
9.5 STAGE I
9.6 STAGE 0
10 GLOBAL LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE
10.1 OVERVIEW
10.2 SECONDARY LIVER CANCER
10.2.1 HEMANGIOMA
10.2.2 HEPATIC ADENOMA
10.2.3 FOCAL NODULAR HYPERPLASIA
10.3 PRIMARY LIVER CANCER
10.3.1 HEPATOCELLULAR CARCINOMA (HCC)
10.3.2 INTRAHEPATIC CHOLANGIOCARCINOMA (BILE DUCT CANCER)
10.3.3 ANGIOSARCOMA HEMANGIOSARCOMA
10.3.4 HEPATOBLASTOMA
11 GLOBAL LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT
11.1 OVERVIEW
11.2 PLATFORM BASED PRODUCTS
11.2.1 NEXT GENERATION SEQUENCING
11.2.2 MICROARRAYS
11.2.3 PCR
11.2.4 OTHERS
11.3 INSTRUMENT BASED PRODUCTS
11.3.1 IMAGING
11.3.2 BIOPSY
11.4 KITS AND REAGENTS
11.4.1 ELISA TEST KITS
11.4.2 CASSETTE TEST KITS
11.4.3 OTHERS
11.5 OTHER CONSUMABLES
12 GLOBAL LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 SCREENING
12.2.1 PLATFORM BASED PRODUCTS
12.2.2 INSTRUMENT BASED PRODUCTS
12.2.3 KITS AND REAGENTS
12.2.4 OTHER CONSUMABLES
12.3 DIAGNOSTIC AND PREDICTIVE
12.3.1 PLATFORM BASED PRODUCTS
12.3.2 INSTRUMENT BASED PRODUCTS
12.3.3 KITS AND REAGENTS
12.3.4 OTHER CONSUMABLES
12.4 PROGNOSTIC
12.4.1 PLATFORM BASED PRODUCTS
12.4.2 INSTRUMENT BASED PRODUCTS
12.4.3 KITS AND REAGENTS
12.4.4 OTHER CONSUMABLES
12.5 RESEARCH
12.5.1 PLATFORM BASED PRODUCTS
12.5.2 INSTRUMENT BASED PRODUCTS
12.5.3 KITS AND REAGENTS
12.5.4 OTHER CONSUMABLES
13 GLOBAL LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY
13.1 OVERVIEW
13.2 FLUORESCENT IN SITU HYBRIDIZATION
13.3 NEXT GENERATION SEQUENCING
13.4 FLUORIMMUNOASSAY
13.5 COMPARATIVE GENOMIC HYBRIDIZATION
13.6 IMMUNOHISTOCHEMICAL
13.7 OTHERS
14 GLOBAL LIVER CANCER DIAGNOSTICS MARKET, BY GENDER
14.1 OVERVIEW
14.2 MALE
14.3 FEMALE
15 GLOBAL LIVER CANCER DIAGNOSTICS MARKET, BY END USER
15.1 OVERVIEW
15.2 HOSPITALS
15.3 DIAGNOSTIC CENTERS
15.4 CANCER RESEARCH CENTERS
15.5 AMBULATORY SURGICAL CENTERS
15.6 ACADEMIC INSTITUTES
15.7 OTHERS
16 GLOBAL LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 RETAIL SALES
16.4 OTHERS
17 GLOBAL LIVER CANCER DIAGNOSTICS MARKET, BY REGION
17.1 OVERVIEW
17.2 NORTH AMERICA
17.2.1 U.S.
17.2.2 CANADA
17.2.3 MEXICO
17.3 EUROPE
17.3.1 GERMANY
17.3.2 FRANCE
17.3.3 RUSSIA
17.3.4 ITALY
17.3.5 U.K.
17.3.6 SPAIN
17.3.7 TURKEY
17.3.8 NETHERLANDS
17.3.9 BELGIUM
17.3.10 SWITZERLAND
17.3.11 REST OF EUROPE
17.4 ASIA-PACIFIC
17.4.1 CHINA
17.4.2 INDIA
17.4.3 JAPAN
17.4.4 INDONESIA
17.4.5 PHILIPPINES
17.4.6 THAILAND
17.4.7 AUSTRALIA
17.4.8 MALAYSIA
17.4.9 SOUTH KOREA
17.4.10 SINGAPORE
17.4.11 VIETNAM
17.4.12 REST OF ASIA-PACIFIC
17.5 SOUTH AMERICA
17.5.1 BRAZIL
17.5.2 ARGENTINA
17.5.3 REST OF SOUTH AMERICA
17.6 MIDDLE EAST AND AFRICA
17.6.1 SOUTH AFRICA
17.6.2 SAUDI ARABIA
17.6.3 U.A.E.
17.6.4 EGYPT
17.6.5 ISRAEL
17.6.6 REST OF MIDDLE EAST AND AFRICA
18 GLOBAL LIVER CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: GLOBAL
18.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
18.3 COMPANY SHARE ANALYSIS: EUROPE
18.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 F. HOFFMANN-LA ROCHE LTD.
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENT
20.2 KONINLIJKE PHILIPS N.V.
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENT
20.3 THERMO FISHER SCIENTIFIC INC.
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 COMPANY SHARE ANALYSIS
20.3.4 PRODUCT PORTFOLIO
20.3.5 RECENT DEVELOPMENT
20.4 BD
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 COMPANY SHARE ANALYSIS
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENTS
20.5 SIEMENS HEALTHCARE GMBH
20.5.1 COMPANY SNAPSHOT
20.5.2 REVENUE ANALYSIS
20.5.3 COMPANY SHARE ANALYSIS
20.5.4 PRODUCT PORTFOLIO
20.5.5 RECENT DEVELOPMENT
20.6 AGILENT TECHNOLOGIES, INC.
20.6.1 COMPANY SNAPSHOT
20.6.2 REVENUE ANALYSIS
20.6.3 PRODUCT PORTFOLIO
20.6.4 RECENT DEVELOPMENTS
20.7 ABK BIOMEDICAL INC.
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 AB SCIEX PTE LTD. (SUBSIDIARY OF DANAHER.)
20.8.1 COMPANY SNAPSHOT
20.8.2 REVENUE ANALYSIS
20.8.3 PRODUCT PORTFOLIO
20.8.4 RECENT DEVELOPMENT
20.9 ALTOGEN BIOSYSTEMS
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENT
20.1 BIOCEPT, INC.
20.10.1 COMPANY SNAPSHOT
20.10.2 REVENUE ANALYSIS
20.10.3 PRODUCT PORTFOLIO
20.10.4 RECENT DEVELOPMENT
20.11 BODITECH MED INC.
20.11.1 COMPANY SNAPSHOT
20.11.2 PRODUCT PORTFOLIO
20.11.3 RECENT DEVELOPMENTS
20.12 DIAGNOSTIC BIOSYSTEMS INC.
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENT
20.13 DIAZYME LABORATORIES, INC.
20.13.1 COMPANY SNAPSHOT
20.13.2 PRODUCT PORTFOLIO
20.13.3 RECENT DEVELOPMENT
20.14 ELABSCIENCE BIOTECHNOLOGY INC.
20.14.1 COMPANY SNAPSHOT
20.14.2 PRODUCT PORTFOLIO
20.14.3 RECENT DEVELOPMENT
20.15 EPIGENOMICS AG
20.15.1 COMPANY SNAPSHOT
20.15.2 REVENUE ANALYSIS
20.15.3 PRODUCT PORTFOLIO
20.15.4 RECENT DEVELOPMENT
20.16 FUJIFILM CORPORATION
20.16.1 COMPANY SNAPSHOT
20.16.2 REVENUE ANALYSIS
20.16.3 PRODUCT PORTFOLIO
20.16.4 RECENT DEVELOPMENT
20.17 FUJIREBIO
20.17.1 COMPANY SNAPSHOT
20.17.2 PRODUCT PORTFOLIO
20.17.3 RECENT DEVELOPMENTS
20.18 HIPRO BIOTECHNOLOGY CO., LTD.
20.18.1 COMPANY SNAPSHOT
20.18.2 PRODUCT PORTFOLIO
20.18.3 RECENT DEVELOPMENT
20.19 ILLUMINA, INC.
20.19.1 COMPANY SNAPSHOT
20.19.2 REVENUE ANALYSIS
20.19.3 PRODUCT PORTFOLIO
20.19.4 RECENT DEVELOPMENTS
20.2 MOLGEN
20.20.1 COMPANY SNAPSHOT
20.20.2 PRODUCT PORTFOLIO
20.20.3 RECENT DEVELOPMENT
20.21 QIAGEN
20.21.1 COMPANY SNAPSHOT
20.21.2 REVENUE ANALYSIS
20.21.3 PRODUCT PORTFOLIO
20.21.4 RECENT DEVELOPMENT
20.22 Q-LINE BIOTECH PVT LTD.
20.22.1 COMPANY SNAPSHOT
20.22.2 PRODUCT PORTFOLIO
20.22.3 RECENT DEVELOPMENT
20.23 SYSMEX CORPORATION
20.23.1 COMPANY SNAPSHOT
20.23.2 REVENUE ANALYSIS
20.23.3 PRODUCT PORTFOLIO
20.23.4 RECENT DEVELOPMENT
20.24 TEBUBIO
20.24.1 COMPANY SNAPSHOT
20.24.2 PRODUCT PORTFOLIO
20.24.3 RECENT DEVELOPMENT
20.25 TOSOH INDIA PVT. LTD.
20.25.1 COMPANY SNAPSHOT
20.25.2 PRODUCT PORTFOLIO
20.25.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
表のリスト
表1 さまざまな種類の癌 さまざまな種類の癌に対する非侵襲的スクリーニング検査
表2 肝臓がんの発生率
表3 肝臓がんの承認された診断
表4 世界の肝臓がん診断市場、検査タイプ別、2021年～2030年（百万米ドル）
表5 肝臓がん診断における世界の画像診断市場、地域別、2021年～2030年（百万米ドル）
表6 肝臓がん診断における世界の画像検査市場、検査タイプ別、2021年～2030年（百万米ドル）
表7 肝臓がん診断における世界の磁気共鳴画像（MRI）市場、検査タイプ別、2021年～2030年（百万米ドル）
表8 肝臓がん診断における遺伝子検査の世界市場、地域別、2021年～2030年（百万米ドル）
表9 肝臓がん診断における生検の世界市場、地域別、2021年～2030年（百万米ドル）
表10 肝臓がん診断における生検の世界市場、検査タイプ別、2021年～2030年（百万米ドル）
表11 世界の肝臓がん診断市場におけるその他、地域別、2021年～2030年（百万米ドル）
表12 世界の肝臓がん診断市場、がんのステージ別、2021年～2030年（百万米ドル）
表13 肝臓がん診断市場における第3段階、地域別、2021年～2030年（百万米ドル）
表14 肝臓がん診断市場における第2段階、地域別、2021年～2030年（百万米ドル）
表15 肝臓がん診断におけるステージIVの世界市場、地域別、2021年～2030年（百万米ドル）
表16 肝臓がん診断市場におけるステージIの世界規模、地域別、2021年～2030年（百万米ドル）
表17 肝臓がん診断市場における世界のステージ0、地域別、2021年～2030年（百万米ドル）
表18 世界の肝臓がん診断市場、がんの種類別、2021年～2030年（百万米ドル）
表19 肝臓がん診断市場における世界の二次性肝臓がん、地域別、2021年～2030年（百万米ドル）
表20 肝癌診断における腎細胞癌の世界市場、検査タイプ別、2021年～2030年（百万米ドル）
表21 肝臓がん診断における世界の明細胞腎細胞がん市場、地域別、2021年～2030年（百万米ドル）
表22 肝癌診断における世界の明細胞腎細胞癌市場、検査タイプ別、2021年～2030年（百万米ドル）
表23 世界の肝臓がん診断市場、製品別、2021年～2030年（百万米ドル）
表24 肝臓がん診断市場におけるプラットフォームベースの製品の世界市場、地域別、2021年～2030年（百万米ドル）
表25 肝臓がん診断市場におけるプラットフォームベースの製品（製品別）、2021年～2030年（百万米ドル）
表26 肝臓がん診断市場における機器ベースの製品、地域別、2021年～2030年（百万米ドル）
表27 肝臓がん診断市場における機器ベースの製品（製品別）、2021年～2030年（百万米ドル）
表28 肝臓がん診断キットおよび試薬の世界市場、地域別、2021年～2030年（百万米ドル）
表29 肝臓がん診断キットおよび試薬の世界市場、製品別、2021年～2030年（百万米ドル）
表30 肝臓がん診断における世界のその他の消耗品市場、地域別、2021年～2030年（百万米ドル）
表31 世界の肝臓がん診断市場、用途別、2021年～2030年（百万米ドル）
表32 肝臓がん診断における世界のスクリーニング市場、地域別、2021年～2030年（百万米ドル）
表33 肝臓がん診断における世界のスクリーニング市場、製品別、2021年～2030年（百万米ドル）
表34 肝臓がん診断における世界の診断および予測市場、地域別、2021年～2030年（百万米ドル）
表35 肝臓がん診断における世界の診断および予測市場、製品別、2021年～2030年（百万米ドル）
表36 肝臓がん診断における世界の予後市場、地域別、2021年～2030年（百万米ドル）
表37 肝臓がん診断における世界の予後市場、製品別、2021年～2030年（百万米ドル）
表38 肝臓がん診断市場に関する世界調査、地域別、2021年～2030年（百万米ドル）
表39 肝臓がん診断市場における世界的調査、製品別、2021-2030年（百万米ドル）
表40 世界の肝臓がん診断市場、技術別、2021年～2030年（百万米ドル）
表41 肝臓がん診断における蛍光in situハイブリダイゼーションの世界市場、地域別、2021年～2030年（百万米ドル）
表42 肝臓がん診断における次世代シーケンシングの世界市場、地域別、2021年～2030年（百万米ドル）
表43 肝臓がん診断における蛍光免疫測定の世界市場、地域別、2021年～2030年（百万米ドル）
表44 肝臓がん診断におけるゲノムハイブリダイゼーションの世界市場、地域別、2021年～2030年（百万米ドル）
表45 世界の免疫組織化学による肝臓がん診断市場、地域別、2021年～2030年（百万米ドル）
表46 世界の肝臓がん診断市場におけるその他、地域別、2021年～2030年（百万米ドル）
表47 世界の肝臓がん診断市場、性別別、2021年～2030年（百万米ドル）
表48 世界の男性肝癌診断市場、地域別、2021年～2030年（百万米ドル）
表49 世界の肝臓がん診断市場、地域別、2021年～2030年（百万米ドル）
表50 世界の肝臓がん診断市場、エンドユーザー別、2021年～2030年（百万米ドル）
表51 肝臓がん診断市場における世界の病院、地域別、2021年～2030年（百万米ドル）
表52 肝臓がん診断市場における世界の診断センター、地域別、2021年～2030年（百万米ドル）
表53 肝臓がん診断市場における世界のがん研究センター、地域別、2021年～2030年（百万米ドル）
表54 肝臓がん診断市場における世界の外来手術センター、地域別、2021年～2030年（百万米ドル）
表55 肝臓がん診断市場における世界の学術機関、地域別、2021年～2030年（百万米ドル）
表56 世界の肝臓がん診断市場におけるその他、地域別、2021年～2030年（百万米ドル）
表57 世界の肝臓がん診断市場、流通チャネル別、2021年～2030年（百万米ドル）
表58 肝臓がん診断市場における世界直接入札、地域別、2021年～2030年（百万米ドル）
表59 肝臓がん診断市場における世界の小売売上高、地域別、2021年～2030年（百万米ドル）
表60 世界の肝臓がん診断市場におけるその他、地域別、2021年～2030年（百万米ドル）
表61 世界の肝臓がん診断市場、地域別、2021年～2030年（百万米ドル）
表62 北米肝臓がん診断市場、国別、2021年～2030年（百万米ドル）
表63 北米肝臓がん診断市場、検査タイプ別、2021年～2030年（百万米ドル）
表64 北米の肝臓がん診断における画像検査市場、検査タイプ別、2021年～2030年（百万米ドル）
表65 北米の肝臓がん診断における磁気共鳴画像（MRI）市場、検査タイプ別 2021-2030年（百万米ドル）
表66 北米の肝癌診断における生検市場、検査タイプ別、2021年～2030年（百万米ドル）
表67 北米肝臓がん診断市場、がんステージ別、2021年～2030年（百万米ドル）
表68 北米肝臓がん診断市場、がんの種類別、2021年～2030年（百万米ドル）
表69 北米二次肝がん肝がん診断市場、がん種別、2021年～2030年（百万米ドル）
表70 北米原発性肝がん 肝がん診断市場、がんの種類別、2021年～2030年（百万米ドル）
表71 北米肝臓がん診断市場、製品別、2021年～2030年（百万米ドル）
表 72 北米の肝臓がん診断市場におけるプラットフォームベース製品、製品別、2021-2030 年 (百万米ドル)
表73 北米の肝臓がん診断市場における機器ベースの製品、製品別、2021年～2030年（百万米ドル）
表74 北米肝臓がん診断キットおよび試薬市場、製品別、2021年～2030年（百万米ドル）
表75 北米肝臓がん診断市場、技術別、2021年～2030年（百万米ドル）
表76 北米肝臓がん診断市場、用途別、2021年～2030年（百万米ドル）
表77 北米の肝臓がんスクリーニング診断市場、用途別、2021年～2030年（百万米ドル）
表 78 北米の肝臓がん診断および予測市場、用途別、2021-2030年（百万米ドル）
表 79 北米肝臓がん診断市場における予後予測、用途別、2021-2030年（百万米ドル）
表80 北米肝臓がん診断市場におけるアプリケーション別調査、2021年～2030年（百万米ドル）
表81 北米肝臓がん診断市場、性別別、2021年～2030年（百万米ドル）
表82 北米肝臓がん診断市場、エンドユーザー別、2021年～2030年（百万米ドル）
表83 北米肝臓がん診断市場、流通チャネル別、2021年～2030年（百万米ドル）
表84 米国肝臓がん診断市場、検査タイプ別、2021年～2030年（百万米ドル）
表85 米国肝臓がん診断市場における画像検査、検査タイプ別、2021年～2030年（百万米ドル）
表86 米国の肝臓がん診断における磁気共鳴画像（MRI）市場、検査タイプ別 2021-2030年（百万米ドル）
表87 米国の肝癌診断における生検市場、検査タイプ別、2021年～2030年（百万米ドル）
表88 米国肝臓がん診断市場、がんステージ別、2021年～2030年（百万米ドル）
表89 米国肝臓がん診断市場、がんの種類別、2021年～2030年（百万米ドル）
TABLE 90 U.S. SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 91 U.S. PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 92 U.S. LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 93 U.S. PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 94 U.S. INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 95 U.S. KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 96 U.S. LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 97 U.S. LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 98 U.S. SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 99 U.S. DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 100 U.S. PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 101 U.S. RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 102 U.S. LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 103 U.S. LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 104 U.S. LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 105 CANADA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 106 CANADA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 107 CANADA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 108 CANADA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 109 CANADA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 110 CANADA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 111 CANADA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 112 CANADA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 113 CANADA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 114 CANADA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 115 CANADA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 116 CANADA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 117 CANADA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 118 CANADA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 119 CANADA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
表 120 カナダの肝臓がん診断および予測市場、用途別、2021-2030年（百万米ドル）
表 121 カナダの肝臓がん診断市場における予後、用途別、2021-2030 年 (百万米ドル)
表122 カナダの肝臓がん診断市場に関する研究、用途別、2021年～2030年（百万米ドル）
表123 カナダの肝臓がん診断市場、性別別、2021年～2030年（百万米ドル）
表 124 カナダの肝臓がん診断市場、エンドユーザー別、2021-2030 年 (百万米ドル)
表125 カナダの肝臓がん診断市場、流通チャネル別、2021年～2030年（百万米ドル）
表126 メキシコの肝臓がん診断市場、検査タイプ別、2021年～2030年（百万米ドル）
表127 メキシコの肝臓がん診断における画像検査市場、検査タイプ別、2021年～2030年（百万米ドル）
表128 メキシコの肝臓がん診断における磁気共鳴画像（MRI）市場、検査タイプ別 2021-2030年（百万米ドル）
表129 メキシコの肝臓がん診断における生検市場、検査タイプ別、2021年～2030年（百万米ドル）
表130 メキシコの肝臓がん診断市場、がんのステージ別、2021年～2030年（百万米ドル）
表131 メキシコの肝臓がん診断市場、がんの種類別、2021年～2030年（百万米ドル）
表 132 メキシコの二次性肝癌 肝癌診断市場、癌の種類別、2021-2030年 (百万米ドル)
表133 メキシコの原発性肝癌 肝癌診断市場、癌の種類別、2021年～2030年（百万米ドル）
表 134 メキシコの肝臓がん診断市場、製品別、2021-2030年 (百万米ドル)
表 135 メキシコの肝臓がん診断市場におけるプラットフォームベース製品、製品別、2021-2030 年 (百万米ドル)
表 136 メキシコの肝臓がん診断市場における機器ベースの製品、製品別、2021-2030 年 (百万米ドル)
表 137 メキシコの肝臓がん診断キットおよび試薬市場、製品別、2021-2030 年 (百万米ドル)
表 138 メキシコの肝臓がん診断市場、技術別、2021-2030 年 (百万米ドル)
表139 メキシコの肝臓がん診断市場、用途別、2021年～2030年（百万米ドル）
表 140 メキシコの肝臓がん診断市場、用途別、2021-2030 年 (百万米ドル)
表 141 メキシコの肝臓がん診断および予測市場、用途別、2021-2030 年 (百万米ドル)
表 142 メキシコの肝臓がん診断市場における予後、用途別、2021-2030 年 (百万米ドル)
表 143 メキシコの肝臓がん診断市場に関する研究、用途別、2021-2030 年 (百万米ドル)
表144 メキシコの肝臓がん診断市場、性別別、2021年～2030年（百万米ドル）
表 145 メキシコの肝臓がん診断市場、エンドユーザー別、2021-2030 年 (百万米ドル)
表146 メキシコの肝臓がん診断市場、流通チャネル別、2021年～2030年（百万米ドル）
表 147 欧州肝臓がん診断市場、国別、2021-2030年 (百万米ドル)
表148 欧州肝臓がん診断市場、検査タイプ別、2021年～2030年（百万米ドル）
表149 ヨーロッパの肝臓がん診断における画像検査市場、検査タイプ別、2021年～2030年（百万米ドル）
表 150 欧州の肝臓がん診断における磁気共鳴画像（MRI）市場、検査タイプ別 2021-2030 年（百万米ドル）
表151 ヨーロッパの肝臓がん診断における生検市場、検査タイプ別、2021年～2030年（百万米ドル）
表 152 欧州肝臓がん診断市場、がんステージ別、2021-2030年（百万米ドル）
表153 欧州肝臓がん診断市場、がんの種類別、2021年～2030年（百万米ドル）
表154 欧州における二次性肝がん 肝がん診断市場、がんの種類別、2021年～2030年（百万米ドル）
表 155 ヨーロッパの原発性肝がん 肝がん診断市場、がんの種類別、2021-2030年 (百万米ドル)
表 156 欧州肝臓がん診断市場、製品別、2021-2030年 (百万米ドル)
表 157 欧州の肝臓がん診断市場におけるプラットフォームベース製品、製品別、2021-2030 年 (百万米ドル)
表 158 欧州の肝臓がん診断市場における機器ベースの製品、製品別、2021-2030 年 (百万米ドル)
表 159 ヨーロッパの肝臓がん診断キットおよび試薬市場、製品別、2021-2030年 (百万米ドル)
表 160 欧州肝臓がん診断市場、技術別、2021-2030年（百万米ドル）
表161 欧州肝臓がん診断市場、用途別、2021年～2030年（百万米ドル）
表 162 欧州の肝臓がんスクリーニング診断市場、用途別、2021-2030年（百万米ドル）
表 163 欧州の肝臓がん診断および予測市場、用途別、2021-2030年 (百万米ドル)
表 164 欧州肝臓がん診断市場、用途別、2021-2030年（百万米ドル）
表 165 ヨーロッパの肝臓がん診断市場、用途別、2021-2030 年 (百万米ドル)
表166 欧州肝臓がん診断市場、性別別、2021年～2030年（百万米ドル）
表 167 欧州肝臓がん診断市場、エンドユーザー別、2021-2030年（百万米ドル）
表 168 欧州肝臓がん診断市場、流通チャネル別、2021-2030年（百万米ドル）
表 169 ドイツの肝臓がん診断市場、検査タイプ別、2021-2030年（百万米ドル）
表170 ドイツの肝臓がん診断における画像検査市場、検査タイプ別、2021年～2030年（百万米ドル）
表171 ドイツの肝臓がん診断における磁気共鳴画像（MRI）市場、検査タイプ別 2021-2030年（百万米ドル）
表 172 ドイツの肝臓がん診断における生検市場、検査タイプ別、2021-2030年（百万米ドル）
表 173 ドイツの肝臓がん診断市場、がんのステージ別、2021-2030 年 (百万米ドル)
表 174 ドイツの肝臓がん診断市場、がんの種類別、2021-2030 年 (百万米ドル)
表 175 ドイツ 二次性肝がん 肝がん診断市場、がんの種類別、2021-2030年 (百万米ドル)
表 176 ドイツ 肝癌診断市場における原発性肝癌、癌の種類別、2021-2030年 (百万米ドル)
表 177 ドイツの肝臓がん診断市場、製品別、2021-2030年 (百万米ドル)
表 178 ドイツ 肝臓がん診断市場におけるプラットフォームベース製品、製品別、2021-2030 年 (百万米ドル)
TABLE 179 GERMANY INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 180 GERMANY KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 181 GERMANY LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 182 GERMANY LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 183 GERMANY SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 184 GERMANY DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 185 GERMANY PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 186 GERMANY RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 187 GERMANY LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 188 GERMANY LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 189 GERMANY LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 190 FRANCE LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 191 FRANCE IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 192 FRANCE MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 193 FRANCE BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 194 FRANCE LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 195 FRANCE LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 196 FRANCE SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 197 FRANCE PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 198 FRANCE LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 199 FRANCE PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 200 FRANCE INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 201 FRANCE KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 202 FRANCE LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 203 FRANCE LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 204 FRANCE SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 205 FRANCE DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 206 FRANCE PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 207 FRANCE RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 208 FRANCE LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 209 FRANCE LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 210 FRANCE LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 211 RUSSIA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 212 RUSSIA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 213 RUSSIA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 214 RUSSIA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 215 RUSSIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 216 RUSSIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 217 RUSSIA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 218 RUSSIA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 219 RUSSIA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 220 RUSSIA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 221 RUSSIA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 222 RUSSIA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 223 RUSSIA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 224 RUSSIA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 225 RUSSIA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 226 RUSSIA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 227 RUSSIA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 228 RUSSIA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 229 RUSSIA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 230 RUSSIA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 231 RUSSIA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 232 ITALY LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 233 ITALY IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 234 ITALY MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 235 ITALY BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 236 ITALY LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 237 ITALY LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 238 ITALY SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 239 ITALY PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 240 ITALY LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 241 ITALY PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 242 ITALY INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 243 ITALY KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 244 ITALY LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 245 ITALY LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 246 ITALY SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 247 ITALY DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 248 ITALY PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 249 ITALY RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 250 ITALY LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 251 ITALY LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 252 ITALY LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 253 U.K. LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 254 U.K. IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 255 U.K. MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 256 U.K. BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 257 U.K. LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 258 U.K. LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 259 U.K. SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 260 U.K. PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 261 U.K. LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 262 U.K. PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 263 U.K. INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 264 U.K. KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 265 U.K. LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 266 U.K. LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 267 U.K. SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 268 U.K. DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 269 U.K. PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 270 U.K. RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 271 U.K. LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 272 U.K. LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 273 U.K. LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 274 SPAIN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 275 SPAIN IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 276 SPAIN MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 277 SPAIN BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 278 SPAIN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 279 SPAIN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 280 SPAIN SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 281 SPAIN PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 282 SPAIN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 283 SPAIN PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 284 SPAIN INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 285 SPAIN KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 286 SPAIN LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 287 SPAIN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 288 SPAIN SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 289 SPAIN DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 290 SPAIN PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 291 SPAIN RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 292 SPAIN LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 293 SPAIN LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 294 SPAIN LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 295 TURKEY LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 296 TURKEY IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 297 TURKEY MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 298 TURKEY BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 299 TURKEY LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 300 TURKEY LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 301 TURKEY SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 302 TURKEY PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 303 TURKEY LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 304 TURKEY PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 305 TURKEY INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 306 TURKEY KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 307 TURKEY LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 308 TURKEY LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 309 TURKEY SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 310 TURKEY DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 311 TURKEY PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 312 TURKEY RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 313 TURKEY LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 314 TURKEY LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 315 TURKEY LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 316 NETHERLANDS LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 317 NETHERLANDS IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 318 NETHERLANDS MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 319 NETHERLANDS BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 320 NETHERLANDS LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 321 NETHERLANDS LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 322 NETHERLANDS SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 323 NETHERLANDS PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 324 NETHERLANDS LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 325 NETHERLANDS PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 326 NETHERLANDS INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
表 327 オランダの肝臓がん診断キットおよび試薬市場、製品別、2021-2030年（百万米ドル）
表 328 オランダの肝臓がん診断市場、技術別、2021-2030年（百万米ドル）
表 329 オランダの肝臓がん診断市場、用途別、2021-2030年（百万米ドル）
表 330 オランダの肝臓がん診断市場におけるスクリーニング、用途別、2021-2030年 (百万米ドル)
表 331 オランダの肝臓がん診断および予測市場、用途別、2021-2030年（百万米ドル）
表 332 オランダの肝臓がん診断市場における予後、用途別、2021-2030 年 (百万米ドル)
表 333 オランダの肝臓がん診断市場に関する研究、用途別、2021-2030年 (百万米ドル)
表 334 オランダの肝臓がん診断市場、性別別、2021-2030年（百万米ドル）
表 335 オランダの肝臓がん診断市場、エンドユーザー別、2021-2030 年 (百万米ドル)
表 336 オランダの肝臓がん診断市場、流通チャネル別、2021-2030年（百万米ドル）
表 337 ベルギーの肝臓がん診断市場、検査タイプ別、2021-2030年（百万米ドル）
表 338 ベルギーの肝臓がん診断における画像検査市場、検査タイプ別、2021-2030年（百万米ドル）
表 339 ベルギーの肝臓がん診断における磁気共鳴画像（MRI）市場、検査タイプ別 2021-2030 年（百万米ドル）
表 340 ベルギーの肝臓がん診断における生検市場、検査タイプ別、2021-2030年（百万米ドル）
表 341 ベルギーの肝臓がん診断市場、がんのステージ別、2021-2030 年 (百万米ドル)
表 342 ベルギーの肝臓がん診断市場、がんの種類別、2021-2030年（百万米ドル）
表 343 ベルギーの二次性肝癌 肝癌診断市場、癌の種類別、2021-2030年 (百万米ドル)
表 344 ベルギーの肝臓がん診断市場における原発性肝臓がん、がんの種類別、2021-2030年（百万米ドル）
表 345 ベルギーの肝臓がん診断市場、製品別、2021-2030年 (百万米ドル)
表 346 ベルギーの肝臓がん診断市場におけるプラットフォームベース製品、製品別、2021-2030年 (百万米ドル)
表 347 ベルギーの肝臓がん診断市場における機器ベースの製品、製品別、2021-2030年 (百万米ドル)
表 348 ベルギーの肝臓がん診断キットおよび試薬市場、製品別、2021-2030年（百万米ドル）
表 349 ベルギーの肝臓がん診断市場、技術別、2021-2030年 (百万米ドル)
表 350 ベルギーの肝臓がん診断市場、用途別、2021-2030年 (百万米ドル)
表 351 ベルギーの肝臓がんスクリーニング診断市場、用途別、2021-2030年（百万米ドル）
表 352 ベルギーの肝臓がん診断および予測市場、用途別、2021-2030年（百万米ドル）
表 353 ベルギーの肝臓がん診断市場における予後、用途別、2021-2030年（百万米ドル）
表 354 ベルギーの肝臓がん診断市場に関する研究、用途別、2021-2030年 (百万米ドル)
表 355 ベルギーの肝臓がん診断市場、性別別、2021-2030年（百万米ドル）
表 356 ベルギーの肝臓がん診断市場、エンドユーザー別、2021-2030 年 (百万米ドル)
表 357 ベルギーの肝臓がん診断市場、流通チャネル別、2021-2030年（百万米ドル）
表 358 スイスの肝臓がん診断市場、検査タイプ別、2021-2030年（百万米ドル）
表 359 スイスの肝臓がん診断における画像検査市場、検査タイプ別、2021-2030年（百万米ドル）
表360 スイスの肝臓がん診断における磁気共鳴画像（MRI）市場、検査タイプ別 2021-2030年（百万米ドル）
表 361 スイスの肝臓がん診断における生検市場、検査タイプ別、2021-2030年（百万米ドル）
表 362 スイスの肝臓がん診断市場、がんのステージ別、2021-2030年（百万米ドル）
表 363 スイスの肝臓がん診断市場、がんの種類別、2021-2030年（百万米ドル）
表 364 スイスの肝臓がん診断市場における二次性肝臓がん、がんの種類別、2021-2030年（百万米ドル）
表 365 スイスの肝臓がん診断市場における原発性肝臓がん、がんの種類別、2021-2030年 (百万米ドル)
表 366 スイスの肝臓がん診断市場、製品別、2021-2030年（百万米ドル）
表 367 スイスの肝臓がん診断市場におけるプラットフォームベース製品、製品別、2021-2030年 (百万米ドル)
表 368 スイスの肝臓がん診断市場における機器ベースの製品、製品別、2021-2030年（百万米ドル）
表 369 スイスの肝臓がん診断キットおよび試薬市場、製品別、2021-2030年（百万米ドル）
表 370 スイスの肝臓がん診断市場、技術別、2021-2030年（百万米ドル）
表 371 スイスの肝臓がん診断市場、用途別、2021-2030年（百万米ドル）
表 372 スイスの肝臓がん診断市場におけるスクリーニング、用途別、2021-2030年（百万米ドル）
表 373 スイスの肝臓がん診断および予測市場、用途別、2021-2030年（百万米ドル）
表 374 スイスの肝臓がん診断市場における予後、用途別、2021-2030年（百万米ドル）
表 375 スイスの肝臓がん診断市場に関する研究、用途別、2021-2030年 (百万米ドル)
表 376 スイスの肝臓がん診断市場、性別別、2021-2030年（百万米ドル）
表 377 スイスの肝臓がん診断市場、エンドユーザー別、2021-2030年（百万米ドル）
表 378 スイスの肝臓がん診断市場、流通チャネル別、2021-2030年（百万米ドル）
表 379 ヨーロッパのその他の地域の肝臓がん診断市場、検査タイプ別、2021-2030年（百万米ドル）
表 380 アジア太平洋地域の肝臓がん診断市場、国別、2021-2030年（百万米ドル）
表 381 アジア太平洋地域の肝臓がん診断市場、検査タイプ別、2021-2030年（百万米ドル）
表 382 アジア太平洋地域の肝臓がん診断における画像検査市場、検査タイプ別、2021-2030年（百万米ドル）
表 383 アジア太平洋地域の肝臓がん診断における磁気共鳴画像（MRI）市場、検査タイプ別 2021-2030 年（百万米ドル）
TABLE 384 ASIA-PACIFIC BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 385 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 386 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 387 ASIA-PACIFIC SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 388 ASIA-PACIFIC PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 389 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 390 ASIA-PACIFIC PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 391 ASIA-PACIFIC INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 392 ASIA-PACIFIC KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 393 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 394 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 395 ASIA-PACIFIC SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 396 ASIA-PACIFIC DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 397 ASIA-PACIFIC PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 398 ASIA-PACIFIC RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 399 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 400 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 401 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 402 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 403 CHINA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 404 CHINA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 405 CHINA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 406 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 407 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 408 CHINA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 409 CHINA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 410 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 411 CHINA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 412 CHINA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 413 CHINA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 414 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 415 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 416 CHINA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 417 CHINA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 418 CHINA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 419 CHINA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 420 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 421 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 422 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 423 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 424 INDIA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 425 INDIA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 426 INDIA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 427 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 428 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 429 INDIA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 430 INDIA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 431 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 432 INDIA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 433 INDIA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 434 INDIA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 435 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 436 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 437 INDIA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 438 INDIA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 439 INDIA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 440 INDIA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 441 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 442 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 443 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 444 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 445 JAPAN IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 446 JAPAN MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 447 JAPAN BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 448 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 449 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 450 JAPAN SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 451 JAPAN PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 452 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 453 JAPAN PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 454 JAPAN INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 455 JAPAN KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 456 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 457 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 458 JAPAN SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 459 JAPAN DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 460 JAPAN PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 461 JAPAN RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 462 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 463 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 464 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 465 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 466 INDONESIA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 467 INDONESIA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 468 INDONESIA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 469 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 470 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 471 INDONESIA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 472 INDONESIA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 473 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 474 INDONESIA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 475 INDONESIA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 476 INDONESIA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 477 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 478 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 479 INDONESIA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 480 INDONESIA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 481 INDONESIA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 482 INDONESIA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 483 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 484 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 485 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 486 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 487 PHILIPPINES IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 488 PHILIPPINES MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 489 PHILIPPINES BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 490 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 491 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 492 PHILIPPINES SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 493 PHILIPPINES PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 494 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 495 PHILIPPINES PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 496 PHILIPPINES INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 497 PHILIPPINES KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 498 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 499 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 500 PHILIPPINES SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 501 PHILIPPINES DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 502 PHILIPPINES PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 503 PHILIPPINES RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 504 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 505 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 506 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 507 THAILAND LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 508 THAILAND IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 509 THAILAND MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 510 THAILAND BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 511 THAILAND LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 512 THAILAND LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 513 THAILAND SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 514 THAILAND PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 515 THAILAND LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 516 THAILAND PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 517 THAILAND INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 518 THAILAND KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 519 THAILAND LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 520 THAILAND LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 521 THAILAND SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 522 THAILAND DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 523 THAILAND PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 524 THAILAND RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 525 THAILAND LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 526 THAILAND LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 527 THAILAND LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 528 AUSTRALIA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 529 AUSTRALIA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 530 AUSTRALIA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 531 AUSTRALIA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 532 AUSTRALIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 533 AUSTRALIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 534 AUSTRALIA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 535 AUSTRALIA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 536 AUSTRALIA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 537 AUSTRALIA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 538 AUSTRALIA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 539 AUSTRALIA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 540 AUSTRALIA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 541 AUSTRALIA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 542 AUSTRALIA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 543 AUSTRALIA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 544 AUSTRALIA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 545 AUSTRALIA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 546 AUSTRALIA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 547 AUSTRALIA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 548 AUSTRALIA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 549 MALAYSIA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 550 MALAYSIA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 551 MALAYSIA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 552 MALAYSIA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 553 MALAYSIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 554 MALAYSIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 555 MALAYSIA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 556 MALAYSIA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 557 MALAYSIA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 558 MALAYSIA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 559 MALAYSIA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 560 MALAYSIA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 561 MALAYSIA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 562 MALAYSIA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 563 MALAYSIA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 564 MALAYSIA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 565 MALAYSIA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 566 MALAYSIA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 567 MALAYSIA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 568 MALAYSIA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 569 MALAYSIA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 570 SOUTH KOREA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 571 SOUTH KOREA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 572 SOUTH KOREA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 573 SOUTH KOREA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 574 SOUTH KOREA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 575 SOUTH KOREA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 576 SOUTH KOREA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 577 SOUTH KOREA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 578 SOUTH KOREA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 579 SOUTH KOREA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 580 SOUTH KOREA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 581 SOUTH KOREA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 582 SOUTH KOREA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 583 SOUTH KOREA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 584 SOUTH KOREA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 585 SOUTH KOREA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 586 SOUTH KOREA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 587 SOUTH KOREA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 588 SOUTH KOREA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 589 SOUTH KOREA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 590 SOUTH KOREA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 591 SINGAPORE LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 592 SINGAPORE IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 593 SINGAPORE MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 594 SINGAPORE BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 595 SINGAPORE LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 596 SINGAPORE LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 597 SINGAPORE SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 598 SINGAPORE PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 599 SINGAPORE LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 600 SINGAPORE PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 601 SINGAPORE INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 602 SINGAPORE KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 603 SINGAPORE LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 604 SINGAPORE LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 605 SINGAPORE SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 606 SINGAPORE DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 607 SINGAPORE PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 608 SINGAPORE RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 609 SINGAPORE LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 610 SINGAPORE LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 611 SINGAPORE LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 612 VIETNAM LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 613 VIETNAM IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 614 VIETNAM MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 615 VIETNAM BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 616 VIETNAM LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 617 VIETNAM LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 618 VIETNAM SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 619 VIETNAM PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 620 VIETNAM LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 621 VIETNAM PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 622 VIETNAM INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 623 VIETNAM KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 624 VIETNAM LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 625 VIETNAM LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 626 VIETNAM SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 627 VIETNAM DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 628 VIETNAM PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 629 VIETNAM RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 630 VIETNAM LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 631 VIETNAM LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 632 VIETNAM LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 633 REST OF ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 634 SOUTH AMERICA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 635 SOUTH AMERICA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 636 SOUTH AMERICA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 637 SOUTH AMERICA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 638 SOUTH AMERICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 639 SOUTH AMERICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 640 SOUTH AMERICA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 641 SOUTH AMERICA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 642 SOUTH AMERICA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 643 SOUTH AMERICA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
表 644 南米の肝臓がん診断市場における機器ベースの製品、製品別、2021-2030年 (百万米ドル)
表 645 南米肝臓がん診断キットおよび試薬市場、製品別、2021-2030年（百万米ドル）
表 646 南米の肝臓がん診断市場、技術別、2021-2030年（百万米ドル）
表 647 南米の肝臓がん診断市場、用途別、2021-2030年（百万米ドル）
表 648 南米の肝臓がんスクリーニング診断市場、用途別、2021-2030年（百万米ドル）
表 649 南米の肝臓がん診断および予測市場、用途別、2021-2030年（百万米ドル）
表 650 南米肝臓がん診断市場における予後、用途別、2021-2030年（百万米ドル）
表 651 南米肝臓がん診断市場における研究、用途別、2021-2030年（百万米ドル）
表 652 南米の肝臓がん診断市場、性別別、2021-2030年（百万米ドル）
表 653 南米肝臓がん診断市場、エンドユーザー別、2021-2030年（百万米ドル）
表 654 南米の肝臓がん診断市場、流通チャネル別、2021-2030年（百万米ドル）
表 655 ブラジルの肝臓がん診断市場、検査タイプ別、2021-2030年（百万米ドル）
表 656 ブラジルの肝臓がん診断における画像検査市場、検査タイプ別、2021-2030年（百万米ドル）
表 657 ブラジルの肝臓がん診断における磁気共鳴画像（MRI）市場、検査タイプ別 2021-2030 年（百万米ドル）
表 658 ブラジルの肝臓がん診断における生検市場、検査タイプ別、2021-2030年（百万米ドル）
表 659 ブラジルの肝臓がん診断市場、がんのステージ別、2021-2030年（百万米ドル）
表 660 ブラジルの肝臓がん診断市場、がんの種類別、2021-2030年（百万米ドル）
表 661 ブラジルの二次性肝癌 肝癌診断市場、癌の種類別、2021-2030年 (百万米ドル)
表 662 ブラジルの肝臓がん診断市場における原発性肝臓がん、がんの種類別、2021-2030年（百万米ドル）
表 663 ブラジルの肝臓がん診断市場、製品別、2021-2030年（百万米ドル）
表 664 ブラジルの肝臓がん診断市場におけるプラットフォームベース製品、製品別、2021-2030年 (百万米ドル)
表 665 ブラジルの肝臓がん診断市場における機器ベースの製品、製品別、2021-2030年 (百万米ドル)
表 666 ブラジルの肝臓がん診断キットおよび試薬市場、製品別、2021-2030年（百万米ドル）
表 667 ブラジルの肝臓がん診断市場、技術別、2021-2030年（百万米ドル）
表 668 ブラジルの肝臓がん診断市場、用途別、2021-2030年（百万米ドル）
表 669 ブラジルの肝臓がん診断市場におけるスクリーニング、用途別、2021-2030年 (百万米ドル)
表 670 ブラジルの肝臓がん診断および予測市場、用途別、2021-2030年（百万米ドル）
表 671 ブラジルの肝臓がん診断市場における予後、用途別、2021-2030 年 (百万米ドル)
表 672 ブラジルの肝臓がん診断市場に関する研究、用途別、2021-2030 年 (百万米ドル)
表 673 ブラジルの肝臓がん診断市場、性別別、2021-2030年（百万米ドル）
表 674 ブラジルの肝臓がん診断市場、エンドユーザー別、2021-2030 年 (百万米ドル)
表 675 ブラジルの肝臓がん診断市場、流通チャネル別、2021-2030 年 (百万米ドル)
表 676 アルゼンチン肝臓がん診断市場、検査タイプ別、2021-2030年（百万米ドル）
表 677 アルゼンチンの肝臓がん診断における画像検査市場、検査タイプ別、2021-2030年（百万米ドル）
表 678 アルゼンチンの肝臓がん診断における磁気共鳴画像（MRI）市場、検査タイプ別 2021-2030 年（百万米ドル）
表 679 アルゼンチンの肝臓がん診断における生検市場、検査タイプ別、2021-2030年（百万米ドル）
表 680 アルゼンチンの肝臓がん診断市場、がんのステージ別、2021-2030 年 (百万米ドル)
表 681 アルゼンチン肝臓がん診断市場、がんの種類別、2021-2030年（百万米ドル）
表 682 アルゼンチンの二次性肝がん 肝がん診断市場、がんの種類別、2021-2030年 (百万米ドル)
表 683 アルゼンチン 肝癌診断市場における原発性肝癌、癌の種類別、2021-2030年 (百万米ドル)
表 684 アルゼンチン肝臓がん診断市場、製品別、2021-2030年（百万米ドル）
表 685 アルゼンチンの肝臓がん診断市場におけるプラットフォームベース製品、製品別、2021-2030年 (百万米ドル)
表 686 アルゼンチンの肝臓がん診断市場における機器ベースの製品、製品別、2021-2030年 (百万米ドル)
表 687 アルゼンチンの肝臓がん診断キットおよび試薬市場、製品別、2021-2030年（百万米ドル）
表 688 アルゼンチンの肝臓がん診断市場、技術別、2021-2030 年 (百万米ドル)
表 689 アルゼンチンの肝臓がん診断市場、用途別、2021-2030年（百万米ドル）
表 690 アルゼンチンの肝臓がん診断市場におけるスクリーニング、用途別、2021-2030年（百万米ドル）
表 691 アルゼンチンの肝臓がん診断および予測市場、用途別、2021-2030年（百万米ドル）
表 692 アルゼンチン肝臓がん診断市場における予後、用途別、2021-2030年（百万米ドル）
表 693 アルゼンチンの肝臓がん診断市場に関する研究、用途別、2021-2030年 (百万米ドル)
表 694 アルゼンチンの肝臓がん診断市場、性別別、2021-2030年（百万米ドル）
表 695 アルゼンチン肝臓がん診断市場、エンドユーザー別、2021-2030年（百万米ドル）
表 696 アルゼンチンの肝臓がん診断市場、流通チャネル別、2021-2030年（百万米ドル）
表 697 南米のその他の地域の肝臓がん診断市場、検査タイプ別、2021-2030年（百万米ドル）
表 698 中東およびアフリカの肝臓がん診断市場、検査タイプ別、2021-2030年（百万米ドル）
表 699 中東およびアフリカにおける肝臓がん診断用画像検査市場、検査タイプ別、2021-2030年（百万米ドル）
表 700 中東およびアフリカの肝臓がん診断における磁気共鳴画像（MRI）市場、検査タイプ別 2021-2030 年（百万米ドル）
TABLE 701 MIDDLE EAST AND AFRICA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 702 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 703 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 704 MIDDLE EAST AND AFRICA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 705 MIDDLE EAST AND AFRICA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 706 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 707 MIDDLE EAST AND AFRICA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 708 MIDDLE EAST AND AFRICA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 709 MIDDLE EAST AND AFRICA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 710 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 711 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 712 MIDDLE EAST AND AFRICA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 713 MIDDLE EAST AND AFRICA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 714 MIDDLE EAST AND AFRICA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 715 MIDDLE EAST AND AFRICA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 716 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 717 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 718 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 719 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 720 SOUTH AFRICA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 721 SOUTH AFRICA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 722 SOUTH AFRICA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 723 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 724 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 725 SOUTH AFRICA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 726 SOUTH AFRICA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 727 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 728 SOUTH AFRICA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 729 SOUTH AFRICA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 730 SOUTH AFRICA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 731 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 732 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 733 SOUTH AFRICA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 734 SOUTH AFRICA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 735 SOUTH AFRICA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 736 SOUTH AFRICA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 737 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 738 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 739 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 740 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 741 SAUDI ARABIA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 742 SAUDI ARABIA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 743 SAUDI ARABIA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 744 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 745 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 746 SAUDI ARABIA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 747 SAUDI ARABIA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 748 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 749 SAUDI ARABIA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 750 SAUDI ARABIA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 751 SAUDI ARABIA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 752 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 753 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 754 SAUDI ARABIA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 755 SAUDI ARABIA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 756 SAUDI ARABIA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 757 SAUDI ARABIA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 758 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 759 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 760 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 761 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 762 U.A.E IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 763 U.A.E MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 764 U.A.E BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 765 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 766 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 767 U.A.E SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 768 U.A.E PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 769 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 770 U.A.E PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 771 U.A.E INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 772 U.A.E KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 773 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 774 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 775 U.A.E SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 776 U.A.E DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 777 U.A.E PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 778 U.A.E RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 779 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 780 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 781 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 782 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 783 EGYPT IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 784 EGYPT MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 785 EGYPT BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 786 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 787 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 788 EGYPT SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 789 EGYPT PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 790 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 791 EGYPT PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 792 EGYPT INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 793 EGYPT KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 794 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 795 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 796 EGYPT SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 797 EGYPT DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 798 EGYPT PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 799 EGYPT RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 800 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 801 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 802 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 803 ISRAEL LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 804 ISRAEL IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 805 ISRAEL MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION)
TABLE 806 ISRAEL BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 807 ISRAEL LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION)
TABLE 808 ISRAEL LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 809 ISRAEL SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 810 ISRAEL PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 811 ISRAEL LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 812 ISRAEL PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 813 ISRAEL INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 814 ISRAEL KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 815 ISRAEL LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 816 ISRAEL LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 817 ISRAEL SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 818 ISRAEL DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 819 ISRAEL PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 820 ISRAEL RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 821 ISRAEL LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 822 ISRAEL LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 823 ISRAEL LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 824 REST OF MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
図表一覧
FIGURE 1 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 11 GROWING AWARENESS OF LIVER CANCER AND INCREASING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL LIVER CANCER DIAGNOSTICS MARKET FROM 2023 TO 2030
FIGURE 12 THE IMAGING TEST SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL LIVER CANCER DIAGNOSTICS MARKET IN 2023 & 2030
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL LIVER CANCER DIAGNOSTICS MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR LIVER CANCER DIAGNOSTIC MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL LIVER CANCER DIAGNOSTICS MARKET
FIGURE 16 THE GLOBAL MORTALITY RATE DUE TO CANCER
FIGURE 17 INCREASING GLOBAL CANCER RATE IN 2020
FIGURE 18 BARRIERS TO EARLY CANCER DIAGNOSIS AND TREATMENT
FIGURE 19 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022
FIGURE 20 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION)
FIGURE 21 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030)
FIGURE 22 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 23 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY CANCER STAGE, 2022
FIGURE 24 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY CANCER STAGE, 2023-2030 (USD MILLION)
FIGURE 25 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY CANCER STAGE, CAGR (2023-2030)
FIGURE 26 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY CANCER STAGE, LIFELINE CURVE
FIGURE 27 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022
FIGURE 28 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION)
FIGURE 29 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030)
FIGURE 30 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE
FIGURE 31 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY PRODUCT, 2022
FIGURE 32 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 33 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 34 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 35 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY APPLICATION, 2022
FIGURE 36 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 37 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 38 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 39 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, 2022
FIGURE 40 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 41 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 42 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 43 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY GENDER, 2022
FIGURE 44 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY GENDER, 2023-2030 (USD MILLION)
FIGURE 45 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY GENDER, CAGR (2023-2030)
FIGURE 46 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY GENDER, LIFELINE CURVE
FIGURE 47 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY END USER, 2022
FIGURE 48 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 49 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 50 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 51 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 52 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 53 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 54 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 55 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022)
FIGURE 56 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY REGION (2022)
FIGURE 57 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY REGION (2023 & 2030)
FIGURE 58 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY REGION (2022 & 2030)
FIGURE 59 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: BY TEST TYPE (2023-2030)
FIGURE 60 NORTH AMERICA LIVER CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022)
FIGURE 61 NORTH AMERICA LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022)
FIGURE 62 NORTH AMERICA LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 63 NORTH AMERICA LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 64 NORTH AMERICA LIVER CANCER DIAGNOSTICS MARKET: TEST TYPE (2023-2030)
FIGURE 65 EUROPE LIVER CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022)
FIGURE 66 EUROPE LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022)
FIGURE 67 EUROPE LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 68 EUROPE LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 69 EUROPE LIVER CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030)
FIGURE 70 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022)
FIGURE 71 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022)
FIGURE 72 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 73 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 74 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET: TEST TYPE (2023-2030)
FIGURE 75 SOUTH AMERICA LIVER CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022)
FIGURE 76 SOUTH AMERICA LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022)
FIGURE 77 SOUTH AMERICA LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 78 SOUTH AMERICA LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 79 SOUTH AMERICA LIVER CANCER DIAGNOSTICS MARKET: TEST TYPE (2023-2030)
FIGURE 80 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022)
FIGURE 81 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022)
FIGURE 82 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 83 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 84 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET: TEST TYPE (2023-2030)
FIGURE 85 GLOBAL LIVER CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%)
FIGURE 86 NORTH AMERICA LIVER CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%)
FIGURE 87 EUROPE LIVER CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%)
FIGURE 88 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
